Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$20.30 +0.23 (+1.15%)
At close: Oct 2, 2026 · 4:00 PM EDT

Amneal Pharmaceuticals (AMRX) Gross Profit (2017 - 2026)

Updated

Amneal Pharmaceuticals (AMRX) recorded Gross Profit of $334.51 million in Q2 2026, up 16.9% from $286.25 million a year earlier and up 4.5% from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) Gross Profit (2017 - 2026) Analysis & Trends

On a TTM basis, Amneal Pharmaceuticals' Gross Profit came in at $1.23 billion as of Jun 30, 2026, up 14.1% year-over-year; for FY2025, it was $1.11 billion, up 9.1% from FY2024.

  • Annual Gross Profit has increased for six straight years, with a five-year compound annual growth rate of 12.1% (FY2020 to FY2025).
  • Across earlier years, Gross Profit came in at $1.02 billion in FY2024 (+24.4%), $820.57 million in FY2023 (+4.6%), $784.71 million in FY2022 (+2.0%) and $768.97 million in FY2021 (+22.4%).
  • The Q2 2026 figure is the highest quarterly Gross Profit in data going back to Q2 2017.
  • On a year-over-year basis, Gross Profit has increased for ten consecutive quarters, with growth averaging 16.6% over the last eight quarters.
  • Peak year-over-year performance for Gross Profit in the last five years was growth of 48.6% in Q3 2021, against a decline of 11.9% in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $320.11 million (Q1 2026), $297.19 million (Q4 2025) and $273.97 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
API Access

Amneal Pharmaceuticals Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=AMRX&period=max&api_key=YOUR_API_KEY